financetom
Business
financetom
/
Business
/
Avalon GloboCare Receives Hong Kong Patent for Advanced CAR-T, CAR-NK Cell Technology
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avalon GloboCare Receives Hong Kong Patent for Advanced CAR-T, CAR-NK Cell Technology
Jul 14, 2025 6:06 AM

08:32 AM EDT, 07/14/2025 (MT Newswires) -- Avalon GloboCare ( ALBT ) said Monday it granted a new standard patent in Hong Kong for its proprietary CAR-T and CAR-Natural Killer cell technology.

The company said the patent for the technology, co-developed with Hong Kong-based partner Arbele, is valid for 20 years, starting Feb. 21, 2020.

The patented technology would boost the production and effectiveness of CAR-T and CAR-NK cell therapies, particularly in fighting blood cancers, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved